Evidence map›Paper›PMID 40791488›Full record

ArticlebioRxiv : the preprint server for biology2025

MiroSCOPE: An AI-driven digital pathology platform for annotating functional tissue units.

Madeleine R Fenner, Selim Sevim, Guanming Wu, Deidre Beavers, Pengfei Guo, Yucheng Tang, Christopher Z Eddy, Kaoutar Ait-Ahmad, Travis Rice-Stitt, George Thomas and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Madeleine R FennerDepartment of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0002-6676-4543
Selim SevimCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0002-3436-0464
Guanming WuDivision of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA.
Deidre BeaversDivision of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA.
Pengfei GuoNVIDIA, USA.
Yucheng TangNVIDIA, USA.
Christopher Z EddyCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Kaoutar Ait-AhmadCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.ORCID 0009-0004-1713-0706
Travis Rice-StittDepartment of Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR, USA.
George ThomasDepartment of Pathology and Laboratory Medicine, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0001-7416-8840
M J KuykendallCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Vasilis StavrinidesDivision of Surgery and Interventional Science, University College London, London WC1E 6AP, UK.
Mark EmbertonDivision of Surgery and Interventional Science, University College London, London WC1E 6AP, UK.
Daguang XuNVIDIA, USA.
Xubo SongDivision of Oncological Sciences, Oregon Health and Science University, Portland, OR, USA.
S Ece EksiCancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Emek DemirDepartment of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA.ORCID 0000-0002-3663-7113

Funding

High Performance Computing and Machine Learning Infrastructure for Oregon Life SciencesS10OD034224 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLROTT, KYLE · 2023 to 2023
$2.0M
NIH HHS S10 OD034224
6 · The paper itself

Abstract

Cancer tissue analysis in digital pathology is typically conducted across different spatial scales, ranging from high-resolution cell-level modeling to lower-resolution tile-based assessments. However, these perspectives often overlook the structural organization of functional tissue units (FTUs), the small, repeating structures which are crucial to tissue function and key factors during pathological assessment. The incorporation of FTU information is hindered by the need for detailed manual annotations, which are costly and time-consuming to obtain. While artificial intelligence (AI)-based solutions hold great promise to accelerate this process, there is currently no comprehensive workflow for building the large, annotated cohorts required. To remove these roadblocks and advance the development of more interpretable approaches, we developed MiroSCOPE, an end-to-end AI-assisted platform for annotating FTUs at scale, built on QuPath. MiroSCOPE integrates a fine-tunable multiclass segmentation model and curation-specific usability features to enable a human-in-the-loop system that accelerates AI annotation by a pathologist. The system is used to efficiently annotate over 71,900 FTUs on 184 prostate cancer hematoxylin and eosin (H&E)-stained tissue samples and demonstrates ready translation to breast cancer. Furthermore, we publicly release a dataset named Miro-120, consisting of 120 prostate cancer H&E with 30,568 annotations, which can be used by the community as a high-quality resource for FTU-level machine learning aims. In summary, MiroSCOPE provides an adaptable AI-driven platform for annotating functional tissue units, facilitating the use of structural information in digital pathology analyses.

Identifiers

PMID40791488
PMCPMC12338586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.